The chemistry of methylene chloride explains both its industrial appeal and its hazard. The molecule, CH2Cl2, is a tetrahedral organochlorine compound with a molecular weight of 84.93 grams per mole, a boiling point of just 39.75 degrees Celsius and a vapour pressure of roughly 350 torr at 25 degrees Celsius. That volatility means it evaporates rapidly at room temperature, producing dense fumes that accumulate in poorly ventilated spaces. It is colourless, miscible with many other solvents, and carries a sweet, chloroform-like odour that can cause olfactory fatigue, meaning workers may stop noticing it precisely when concentrations become dangerous. Because the compound is denser than air, it can pool in low-lying or enclosed areas, creating suffocation hazards. Anhydrous methylene chloride is non-corrosive to most common metals, but hydrolysis produces hydrochloric acid, which attacks iron and aluminium, so commercial formulations include stabilizers such as propylene oxide, hydroquinone or cyclohexane to limit decomposition.

Industrially, the compound is manufactured by chlorinating methane or methyl chloride at temperatures around 400 to 500 degrees Celsius, a radical reaction that yields a mixture of chloromethanes separated by distillation. Its applications are remarkably broad: paint and varnish stripping, metal degreasing, polyurethane foam blowing, pharmaceutical processing, polycarbonate plastics production, electronics manufacturing, and even decaffeination of coffee, where the US Food and Drug Administration permits residual levels of about 10 parts per million. The Asia-Pacific region, driven by China, India, Japan and South Korea, now constitutes the largest market, fueled by demand for paints, coatings and generic medicines. India alone, which supplies roughly 20 percent of the world’s generic drugs, hosts approximately 3,000 pharmaceutical companies operating more than 10,500 manufacturing facilities, many of which rely on methylene chloride as a process solvent.

Environmental monitoring reveals just how pervasive the chemical has become. About 80 percent of all methylene chloride produced is ultimately released into the atmosphere, where surveys have detected ambient concentrations ranging from zero to 570 micrograms per cubic metre in the United States and up to 9.9 micrograms per cubic metre in Canada. Indoor air can be far worse: in poorly ventilated rooms, concentrations between 460 and 2,980 micrograms per cubic metre have been recorded, and household products such as paint removers and adhesives can generate exposure levels of 15 to 1,770 milligrams per cubic metre during use. The compound also appears in municipal drinking water at 1.1 to 2.0 micrograms per litre, forms as a byproduct of water chlorination, and has been measured in the River Rhine. Food products including spice oleoresins, fumigated grains, seafood, butter and cheese carry trace amounts. Soil and sediment samples from hundreds of hazardous waste sites contain detectable levels, with a geometric mean concentration of about 104 parts per billion.

Once inhaled or ingested, methylene chloride is absorbed rapidly through the lungs and gastrointestinal tract and distributed throughout the body, crossing the blood-brain barrier and the placenta and accumulating preferentially in adipose tissue. Human volunteer studies show that roughly 70 to 75 percent of inhaled vapour is absorbed, with uptake increasing during exercise and in individuals with higher body fat. The compound’s toxicology hinges on two competing metabolic pathways in the liver. The dominant route involves oxidation by the microsomal cytochrome P-450 enzyme CYP2E1, which converts methylene chloride into unstable dichloromethanol, then formyl chloride, and ultimately carbon monoxide. This carbon monoxide binds haemoglobin with an affinity 210 to 270 times greater than oxygen, forming carboxyhaemoglobin, a biomarker that effectively turns methylene chloride poisoning into a slow, internal carbon monoxide poisoning. The oxidative pathway saturates at inhalation concentrations of about 500 parts per million.

The second, minor pathway involves conjugation with glutathione, catalysed by the enzyme GSTT1. Although quantitatively smaller, this route may be the more sinister one for cancer risk: it produces formaldehyde, formic acid and S-chloromethyl glutathione, an electrophile that binds nucleophilic sites on DNA. Studies indicate that the GST pathway is more active in mice and rats than in humans and hamsters, which complicates extrapolation from rodent tumour data, yet the pathway shows no saturation even at inhalation concentrations of 10,000 parts per million. Chronic inhalation studies in mice have produced malignant lung and liver tumours, and rats developed benign and malignant tumours of the lung, liver and mammary gland. Human epidemiological evidence, particularly an increased incidence of biliary tract tumours among workers exposed to methylene chloride alongside 1,2-dichloropropane, drove the IARC’s revision of its carcinogenic classification, and the compound has been linked to cholangiocarcinoma in humans.

Acute exposures tell a grim clinical story. Case reports document a 16-year-old who developed Goodpasture’s syndrome after inhaling solvent vapours at work, a 19-year-old suffering acute tubular necrosis and liver enzyme elevations, and an art student who collapsed within an hour of exposure with a carboxyhaemoglobin level of 50 percent. Perhaps most chilling is the case of a painter who used a methylene chloride-based paint remover in a poorly ventilated room containing a kerosene stove; the combination released lethal phosgene gas, and the painter died within 12 hours. Dermal contact is equally hazardous, producing painful chemical burns that destroy epidermal and dermal lipids, with documented cases of workers left unconscious while partially immersed in the liquid. Because carbon monoxide generated by metabolism continues to form after exposure ends, carboxyhaemoglobin levels can keep rising for one to two hours, and the half-life of carboxyhaemoglobin after methylene chloride exposure extends to about 13 hours, far longer than the 5.3 hours typical after direct carbon monoxide poisoning.

Treatment mirrors carbon monoxide management: immediate removal from exposure, high-flow oxygen therapy and, in severe cases, hyperbaric oxygen, which can shorten the carboxyhaemoglobin half-life to 15 to 20 minutes under 2.5 atmospheres of pressure. Prevention, however, remains the better strategy, and regulators have responded incrementally over decades. NIOSH set an initial exposure limit of 75 parts per million in 1976, later urging minimal exposure after recognizing tumorigenic potential. OSHA tightened its standard from 500 to 25 parts per million over an eight-hour shift, with a short-term limit of 125 parts per million for 15 minutes. The FDA banned methylene chloride in cosmetics and hairsprays in 1989, and in 2019 the EPA issued a final rule banning the manufacture and distribution of methylene chloride paint strippers for retail sale after a series of occupational fatalities. Recommended workplace controls include dedicated ventilated chambers, supplied-air respirators, fume hoods, corrosion-resistant storage containers, personal protective equipment and strict segregation of food and drink from solvent areas.

Encouragingly, viable alternatives are now entering the market. AcraStrip, a semi-aqueous, non-flammable and biodegradable paint-stripping solvent, offers recyclability and zero harmful vapours. Infrared light-wave strippers can loosen multiple layers of paint in 60 seconds without chemicals, while laser cleaning uses nanosecond pulses to vaporize lead and chrome-based coatings with minimal secondary waste. Chemical substitutes include dimethyl carbonate, N-methyl-2-pyrrolidone, propylene carbonate, citrus-based cleaners and bio-derived solvents, alongside purely mechanical methods such as abrasive blasting and scraping. Waste treatment technologies, including UV, UV-titanium dioxide and biotrickling reactors, can convert methylene chloride in waste gas streams into water-soluble byproducts, and the compound is readily biodegraded by Pseudomonas species under both aerobic and anaerobic conditions. The review’s authors argue that green chemistry principles could eliminate methylene chloride from pharmaceutical synthesis entirely, but they caution that more research is needed into its toxicity mechanisms, its human carcinogenic potential and improved disposal techniques. Until then, the one-million-ton-per-year question remains: how long can industry afford a solvent that poisons its workers, its consumers and its atmosphere?

Subject of Research: Toxicology and carcinogenicity of the industrial solvent methylene chloride (dichloromethane), covering its sources, exposure routes, metabolism, ecological effects, regulation and alternatives

Article Title: Sources, exposure, metabolism, transportation, ecological effects, preventive measures and alternatives of carcinogenic methylene chloride: a review

Article References: Kumari, D., Janmeda, P., & Singh, D. (2024). Sources, exposure, metabolism, transportation, ecological effects, preventive measures and alternatives of carcinogenic methylene chloride: a review. Discover Toxicology, 1(1), Article 15. https://doi.org/10.1007/s44339-024-00012-8

Image Credits: AI Generated

DOI: 10.1007/s44339-024-00012-8

Keywords: methylene chloride, dichloromethane, carcinogen, volatile organic compound, carbon monoxide, cytochrome P-450, glutathione S-transferase, occupational exposure, paint strippers, environmental pollution, green chemistry, solvent alternatives